Attitudes and Knowledge About Human Immunodeficiency Virus Pre-Exposure Prophylaxis Among Brazilian Infectious Disease Physicians

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorCERQUEIRA, Natalia Barros
dc.contributor.authorVASCONCELOS, Ricardo
dc.contributor.authorHOJILLA, J. Carlo
dc.contributor.authorKALLAS, Esper Georges
dc.contributor.authorI, Vivian Avelino-Silva
dc.date.accessioned2021-02-18T13:30:28Z
dc.date.available2021-02-18T13:30:28Z
dc.date.issued2020
dc.description.abstractThe objective was to describe levels and predictors of knowledge, attitudes, and willingness to prescribe pre-exposure prophylaxis (PrEP) among Brazilian Infectious Disease (ID) Physicians. The design was a cross-sectional study. We collected information on demographics and attitudes/knowledge about PrEP using an anonymous electronic survey. Willingness to prescribe PrEP, fear of adherence issues, and concerns about risk compensation were addressed in three case vignettes that varied by a single characteristic (i.e., by gender identity, drug use, and socioeconomic status) randomly assigned to physicians. Three hundred seventy ID physicians responded to the survey. Although most identified as informed/well informed about PrEP (75%) and believed PrEP availability to be necessary (38%), concerns with adherence (49%), side effects (38%), risk compensation (28%), and increase in sexually transmitted infection incidence (38%) were raised. We found no statistically significant differences in willingness to prescribe PrEP and concerns around risk compensation across the three case vignettes. ID physicians who declared having a religion reported more concerns about risk compensation compared to those self-identified as atheists (72% vs. 46%,p < .001). Most Brazilian ID physicians reported a positive attitude toward PrEP. Patients' gender identity, drug use, and socioeconomic status were not associated with willingness to prescribe PrEP. However, ID physicians who declared having a religion were more frequently concerned about risk compensation among PrEP users, suggesting that personal beliefs can influence PrEP implementation.eng
dc.description.indexMEDLINEeng
dc.identifier.citationAIDS RESEARCH AND HUMAN RETROVIRUSES, v.36, n.12, p.1047-1053, 2020
dc.identifier.doi10.1089/aid.2019.0281
dc.identifier.eissn1931-8405
dc.identifier.issn0889-2229
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/39223
dc.language.isoeng
dc.publisherMARY ANN LIEBERT, INCeng
dc.relation.ispartofAIDS Research and Human Retroviruses
dc.rightsrestrictedAccesseng
dc.rights.holderCopyright MARY ANN LIEBERT, INCeng
dc.subjecthealth knowledgeeng
dc.subjectattitudeseng
dc.subjectpracticeeng
dc.subjectpre-exposure prophylaxiseng
dc.subjectimplementation scienceeng
dc.subjectHIV infectionseng
dc.subject.otherhealth-care providerseng
dc.subject.otherhiveng
dc.subject.otherprepeng
dc.subject.otherawarenesseng
dc.subject.otherprescriptioneng
dc.subject.otherstigmaeng
dc.subject.othermeneng
dc.subject.othersexeng
dc.subject.wosImmunologyeng
dc.subject.wosInfectious Diseaseseng
dc.subject.wosVirologyeng
dc.titleAttitudes and Knowledge About Human Immunodeficiency Virus Pre-Exposure Prophylaxis Among Brazilian Infectious Disease Physicianseng
dc.typearticleeng
dc.type.categoryoriginal articleeng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.affiliation.countryEstados Unidos
hcfmusp.affiliation.countryisous
hcfmusp.author.externalHOJILLA, J. Carlo:Univ Calif San Francisco, Dept Psychiat, Weill Inst Neurosci, San Francisco, CA USA
hcfmusp.citation.scopus3
hcfmusp.contributor.author-fmusphcNATALIA BARROS CERQUEIRA
hcfmusp.contributor.author-fmusphcRICARDO DE PAULA VASCONCELOS
hcfmusp.contributor.author-fmusphcESPER GEORGES KALLAS
hcfmusp.contributor.author-fmusphcVIVIAN HELENA IIDA AVELINO DA SILVA
hcfmusp.description.beginpage1047
hcfmusp.description.endpage1053
hcfmusp.description.issue12
hcfmusp.description.volume36
hcfmusp.origemWOS
hcfmusp.origem.pubmed32657136
hcfmusp.origem.scopus2-s2.0-85097210765
hcfmusp.origem.wosWOS:000556942100001
hcfmusp.publisher.cityNEW ROCHELLEeng
hcfmusp.publisher.countryUSAeng
hcfmusp.relation.referenceAdams LM, 2016, AIDS CARE, V28, P1154, DOI 10.1080/09540121.2016.1153595eng
hcfmusp.relation.referenceBlackstock OJ, 2017, J GEN INTERN MED, V32, P62, DOI 10.1007/s11606-016-3903-zeng
hcfmusp.relation.referenceBlumenthal J, 2015, AIDS BEHAV, V19, P802, DOI 10.1007/s10461-015-0996-zeng
hcfmusp.relation.referenceCalabrese SK, 2019, AIDS PATIENT CARE ST, V33, P79, DOI 10.1089/apc.2018.0166eng
hcfmusp.relation.referenceCalabrese SK, 2014, AIDS BEHAV, V18, P226, DOI 10.1007/s10461-013-0675-xeng
hcfmusp.relation.referenceChariyalertsak S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024295eng
hcfmusp.relation.referenceDesai M, 2016, HIV MED, V17, P133, DOI 10.1111/hiv.12285eng
hcfmusp.relation.referenceGoodman-Meza D, 2019, AIDS CARE, V31, P1228, DOI 10.1080/09540121.2019.1595523eng
hcfmusp.relation.referenceGrinsztejn B, 2018, LANCET HIV, V4, P1eng
hcfmusp.relation.referenceGrov C, 2019, AIDS BEHAV, V23, P1277, DOI 10.1007/s10461-018-2309-9eng
hcfmusp.relation.referenceHojilla JC, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25103eng
hcfmusp.relation.referenceKerr LRFS, 2013, AIDS, V27, P427, DOI 10.1097/QAD.0b013e32835ad504eng
hcfmusp.relation.referenceKrakower D, 2012, CURR OPIN HIV AIDS, V7, P593, DOI 10.1097/COH.0b013e3283590446eng
hcfmusp.relation.referenceMcGowan CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018462eng
hcfmusp.relation.referenceMimiaga MJ, 2014, AIDS CARE, V26, P684, DOI 10.1080/09540121.2013.845289eng
hcfmusp.relation.referenceMinisterio da Saude: Secretaria de Vigilancia em Saude, 2018, B EP HIV AIDS 2018eng
hcfmusp.relation.referenceMinisterio da Saude: Secretaria de Vigilancia em Saude . Departamento de IST Aids e Hepatites Virais, 2017, PROT CLIN DIR TER PReng
hcfmusp.relation.referenceMullins TLK, 2017, AIDS PATIENT CARE ST, V31, P504, DOI 10.1089/apc.2017.0147eng
hcfmusp.relation.referenceNunn AC, 2017, PLOS ONE, V12, pe0173057eng
hcfmusp.relation.referencePage K, 2017, LANCET HIV, V4, pE52, DOI 10.1016/S2352-3018(16)30208-9eng
hcfmusp.relation.referencePetroll AE, 2017, AIDS BEHAV, V21, P1256, DOI 10.1007/s10461-016-1625-1eng
hcfmusp.relation.referencePetroll AE, 2011, SEX TRANSM DIS, V38, P63, DOI 10.1097/OLQ.0b013e3181ebd50feng
hcfmusp.relation.referencePuro V, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-217eng
hcfmusp.relation.referenceReyniers T, 2018, SEX HEALTH, V15, P606, DOI 10.1071/SH18072eng
hcfmusp.relation.referenceSeidman D, 2016, CONTRACEPTION, V93, P463, DOI 10.1016/j.contraception.2015.12.018eng
hcfmusp.relation.referenceSharma M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105283eng
hcfmusp.relation.referenceSilverman T, 2018, POLYMERS-BASEL, V10, DOI 10.3390/polym10020166eng
hcfmusp.relation.referenceTripathi A, 2012, SOUTH MED J, V105, P199, DOI 10.1097/SMJ.0b013e31824f1a1beng
hcfmusp.relation.referenceUNAIDS, 2018, UNAIDS DAT 2018eng
hcfmusp.relation.referenceVaras-Diaz N., 2014, Journal of the International Association of Providers of AIDS Care, V13, P305, DOI 10.1177/2325957412472935eng
hcfmusp.relation.referenceVaras-Diaz N, 2010, GLOB PUBLIC HEALTH, V5, P295, DOI 10.1080/17441690903436581eng
hcfmusp.relation.referenceWestergaard RP, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-10eng
hcfmusp.relation.referenceWoolf-King SE, 2013, J URBAN HEALTH, V90, P948, DOI 10.1007/s11524-013-9820-0eng
hcfmusp.scopus.lastupdate2024-05-10
relation.isAuthorOfPublication45dc6aed-5f3a-4204-940a-404921741dd4
relation.isAuthorOfPublication269518fc-f3c4-44db-852a-43298ec8fe92
relation.isAuthorOfPublication28071dc0-9dc3-4896-81cf-c90be6515b24
relation.isAuthorOfPublication86c321c7-5cde-4865-b233-ae342a5e5dee
relation.isAuthorOfPublication.latestForDiscovery45dc6aed-5f3a-4204-940a-404921741dd4
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
art_CERQUEIRA_Attitudes_and_Knowledge_About_Human_Immunodeficiency_Virus_PreExposure_2020.PDF
Tamanho:
167.97 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)
Baixar
Coleções
Artigos e Materiais de Revistas Científicas - FM/MIP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/49
Artigos e Materiais de Revistas Científicas - LIM/60
Artigos e Materiais de Revistas Científicas - ODS/03